Literature DB >> 24026361

The evaluation and treatment of prostate-related LUTS in the primary care setting: the next STEP.

Matt T Rosenberg1, David Staskin, John Riley, Grannum Sant, Martin Miner.   

Abstract

The primary care provider is in an optimal position to identify and care for the patient affected by prostate-related lower urinary tract symptoms (BPH-LUTS). This assessment can be readily accomplished with a good history and only a few simple, in-office tests. In some instances, the primary care provider may believe that they do not have the experience, comfort level or time to perform an adequate evaluation of the problem. Therefore, in this article, we describe the function of the lower urinary tract, as well as the rationale behind the medical history, examination and tests needed in order to diagnose and treat, or refer, the patient presenting with BPH-LUTS. We will also update the literature-based STEP (simplified treatment of the enlarged prostate) approach, which was initially published in 2009, to include recently described therapeutic options.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24026361     DOI: 10.1007/s11934-013-0371-4

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  53 in total

1.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

2.  Effect of dutasteride on the risk of prostate cancer.

Authors:  Gerald L Andriole; David G Bostwick; Otis W Brawley; Leonard G Gomella; Michael Marberger; Francesco Montorsi; Curtis A Pettaway; Teuvo L Tammela; Claudio Teloken; Donald J Tindall; Matthew C Somerville; Timothy H Wilson; Ivy L Fowler; Roger S Rittmaster
Journal:  N Engl J Med       Date:  2010-04-01       Impact factor: 91.245

3.  Can benign prostatic hyperplasia be identified in the primary care setting using only simple tests? Results of the Diagnosis IMprovement in PrimAry Care Trial.

Authors:  J Carballido; R Fourcade; A Pagliarulo; F Brenes; A Boye; A Sessa; M Gilson; R Castro
Journal:  Int J Clin Pract       Date:  2011-07-07       Impact factor: 2.503

Review 4.  A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.

Authors:  Michael J Naslund; Martin Miner
Journal:  Clin Ther       Date:  2007-01       Impact factor: 3.393

5.  Hemodynamic interaction study between the alpha1-blocker alfuzosin and the phosphodiesterase-5 inhibitor tadalafil in middle-aged healthy male subjects.

Authors:  François Giuliano; Steven A Kaplan; Marie-Josée Cabanis; Béatrice Astruc
Journal:  Urology       Date:  2006-06       Impact factor: 2.649

6.  Urologic diseases in America project: benign prostatic hyperplasia.

Authors:  John T Wei; Elizabeth Calhoun; Steven J Jacobsen
Journal:  J Urol       Date:  2005-04       Impact factor: 7.450

Review 7.  Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia.

Authors:  Gerald Andriole; Nicholas Bruchovsky; Leland W K Chung; Alvin M Matsumoto; Roger Rittmaster; Claus Roehrborn; David Russell; Donald Tindall
Journal:  J Urol       Date:  2004-10       Impact factor: 7.450

8.  Screening for Prostate Cancer: A Review of the ERSPC and PLCO Trials.

Authors:  Elisabeth Eckersberger; Julia Finkelstein; Helen Sadri; Markus Margreiter; Samir S Taneja; Herbert Lepor; Bob Djavan
Journal:  Rev Urol       Date:  2009

9.  Benign prostatic hyperplasia (BPH) management in the primary care setting.

Authors:  Anil Kapoor
Journal:  Can J Urol       Date:  2012-10       Impact factor: 1.344

10.  Diagnosis of BPH and treatment of LUTS among GPs: a European survey.

Authors:  F Montorsi; D Mercadante
Journal:  Int J Clin Pract       Date:  2013-02       Impact factor: 2.503

View more
  1 in total

1.  Real-world data and treatment patterns of patients with lower urinary tract symptoms due to benign prostatic hyperplasia in Germany: an observational study using health insurance claims data.

Authors:  Arkadiusz Miernik; Jonas Fritzsche; Berit Libutzki; Vanessa Malka; Ido Kilemnik; Damon Mohebbi; Melanie May; Christian Gratzke; Rodrigo Suarez-Ibarrola
Journal:  World J Urol       Date:  2021-07-22       Impact factor: 4.226

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.